AnPac Bio Completes Over 180,000 CDA-Based Cancer Risk Assessment Tests
29 juil. 2020 08h26 HE
|
Anpac Bio, USA
SAN JOSE, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Completed 1st Half Year with Increased ASP and Revenue
13 juil. 2020 08h40 HE
|
Anpac Bio, USA
SAN JOSE, Calif., July 13, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Ranked #3 in Liquid Biopsy Clinical Samples Globally by Frost & Sullivan While Retaining #1 Position and Widening its Lead in China in Cancer Screening
26 juin 2020 08h00 HE
|
Anpac Bio, USA
SAN JOSE, Calif., June 26, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Launches New Immunology Test Product Line
22 juin 2020 08h46 HE
|
Anpac Bio, USA
SAN JOSE, Calif., June 22, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Signs a Record Multi-Million Dollar Contract for Cancer Screening
19 juin 2020 08h46 HE
|
Anpac Bio, USA
SAN JOSE, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Signs a Record Multi-Million Dollar Contract for Cancer Screening
19 juin 2020 08h00 HE
|
Anpac Bio, USA
SAN JOSE, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Announces Appointment of New Chief Financial Officer
02 juin 2020 17h00 HE
|
Anpac Bio, USA
SAN JOSE, Calif., June 02, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Continues to Build Strong Patent Portfolio, with 3rd Patent Granted This Year in the United States
26 mai 2020 08h00 HE
|
Anpac Bio, USA
SAN JOSE, Calif., May 26, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Reports Record Revenue and Number of Cancer Risk Assessment Tests in 2019
18 mai 2020 08h30 HE
|
Anpac Bio, USA
Continued annual revenue growthNumber of commercial CDA (cancer differentiation analysis)-based tests increased 26.0% year-on-yearContinued to gain customers and increase the acceptance of our cancer...
AnPac Files Its Annual Report on Form 20-F
18 mai 2020 08h24 HE
|
Anpac Bio, USA
SAN JOSE, Calif., May 18, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in China and the United...